1.
Rigorous Bivariate Synthesis of Benefit-Risk Profiles for Direct Oral Anticoagulants in Atrial Fibrillation. ST. 2026;2(4). Accessed June 17, 2026. https://www.synthesis-medicine.org/index.php/journal/article/view/12